ÅëÇÕ°Ë»ö
ä¿ëÁ¤º¸
ÇìµåÇåÆÃ
ÀÎÀçÁ¤º¸
Ä¿¹Â´ÏƼ
Àαâ°Ë»ö¾î
:
¿µ¾÷
¸¶ÄÉÆÃ
ÀÓ»ó
¿¬±¸
Ç°Áú°ü¸®
ÀλçÃѹ«
»ý»êÁ÷
¾à»ç
ÀÎÇã°¡
°£È£»ç
- À̹ÌÁöºä -
(400x300)
Seoul sqaure
Canteen
Office
library
CRA ´Ù¼ö ä¿ë
ȸ»ç¸í
Çѱ¹MSD À¯ÇÑȸ»ç
´ëÇ¥ÀÚ
¾Æºê¶óÇÔ º¥¼î¼¢
»ç¿ø¼ö
750¸í
ÀÚº»±Ý
¹ÌÀÔ·Â
»ç¾÷³»¿ë
Á¦¾à
Seoul sqaure
Canteen
Office
library
¸ðÁýÁ÷Á¾
¿¬±¸/ÀÓ»ó/°³¹ß/Åë°è
£¾
ÀÓ»ó BD/RA/QA
±Ù¹«Áö¿ª
¼¿ï
Áß±¸
´ã´ç¾÷¹«
ÀÓ»ó, ¸ð´ÏÅ͸µ
¸ðÁýÀοø
¡Û
¸í
±Ù¹«ÇüÅÂ
ÃßÈÄÇùÀÇ
±Þ¿©»çÇ×
ÃßÈÄÇùÀÇ
º¹¸®ÈÄ»ý
4´ëº¸Çè, °æÁ¶±Ý, ¿¬Â÷, ÀÚ³à ÇÐÀÚ±Ý Áö±Þ, ÁÖ5Àϱٹ«, Á߽ĺñ, ÅðÁ÷±Ý
ÀÚ°Ý¿ä°Ç
¼ºº°
¹«°ü
³ªÀÌ
¹«°ü
ÇзÂ
´ëÇÐ(4³â) Á¹¾÷
¡è
°æ·Â
2³â
¡è
»ó¼¼¸ðÁý³»¿ë
*ä¿ë±â°ü¸í: Çѱ¹MSD (http://msd-korea.com)
*¸ðÁý Á÷¹« : (Sr.)CRA
*¸ðÁý Àοø : 5¸í
*´ã´ç ¾÷¹« :
Acts as primary site contact and site manager throughout all phases of a clinical research study, taking overall responsibility of allocated sites.
•Develops strong site relationships and ensures continuity of site relationships through all phases of the trial.
•Performs clinical study site management/monitoring activities in compliance with ICH-GCP, Sponsor SOPs, Local Laws & Regulations, Protocol, Site Monitoring Plan and associated documents.
•Gains an in-depth understanding of the study protocol and related procedures.
•Coordinates & manages various tasks in collaboration with other sponsor roles to achieve Site Ready.
•Participates & provides inputs on site selection and validation activities.
•Performs remote and on-site monitoring & oversight activities using various tools to ensure:
o Data generated at site are complete, accurate and unbiased
o Subjects¡¯ right, safety and well-being are protected
•Conducts site visits including but not limited to validation visits, initiation visits, monitoring visits, close-out visits and records clear, comprehensive and accurate visit & non-visit contact reports appropriately in a timely manner.
•Collects, reviews, and monitors required regulatory documentation for study start-up, study maintenance and study close-out.
•Communicates with Investigators and site staff on issues related to protocol conduct,
recruitment, retention, protocol deviations, regulatory documentation, site audits/inspections and overall site performance.
•Identifies, assesses and resolves site performance, quality or compliance problems and escalates per defined CRA Escalation Pathway as appropriate in collaboration with CRM, PLM and RCPM.
•Manages and maintains information and documentation in CTMS, eTMF and various other systems as appropriate and per timelines.
•Contributes to CRA team knowledge by acting as process Subject Matter Expert (SME), buddy/mentor and sharing best practices as appropriate/required.
•Supports and/or leads audit/inspection activities as needed
*Áö¿ø ÀÚ°Ý :
-Çʼö Á¶°Ç: ±Û·Î¹ú ½ºÅ͵ð, Oncology monitoring °æ·Â
-¿ì´ë Á¶°Ç: CRO ȤÀº Á¦¾àȸ»ç¿¡¼ CRA 2³â ÀÌ»óÀÇ °æ·ÂÀÌ ÀÖÀ¸½Å ºÐ
*±Ù¹« Á¶°Ç
- °è¾à ÇüÅ : Á¤±ÔÁ÷
- ±Ù¹« ¿äÀÏ/½Ã°£: ¿ù – ±Ý, ¿ÀÀü 7-10½Ã Ãâ±Ù½Ã°£ ¼±Åà °¡´É
- ±Þ¿© : ¸éÁ¢ ÈÄ ÇùÀÇ
- ±Ù¹« ½ÃÀÛÀÏ : 2019³â 9¿ù~10¿ù ÀÔ»ç Èñ¸Á
- º¹¸®ÈÄ»ý :
4´ëº¸Çè, ÅðÁ÷±Ý, Àμ¾Æ¼ºê, ¿¬Â÷, Live it days(ÈÞ°¡), °Ç°°ËÁø, ÀÚ³àÇÐÀÚ±Ý º¸Á¶, ÀÚ»çÀǾàÇ° ÇÒÀÎ, ¹é½Å Á¢Á¾, Family day, ÁÖ 1ȸ ÀçÅñٹ« °¡´É, ¿µ¾î±³À°ºñ Áö¿ø, ÀÚ±â°è¹ßºñ Áö¿ø, ½Ä´ëº¸Á¶ºñ, ÃâÅð±Ùº¸Á¶ºñ, ´Üü»ý¸íº¸Çè, °¢ Á¾ °æÁ¶±Ý Áö¿ø µî
*Áö¿ø ¹æ¹ý : minjung.choi@merck.com À¸·Î ÀÚÀ¯À̷¼ ¼ÛºÎ
*Áö¿ø ÀýÂ÷ : ¼·ù ÀüÇü - ºÎ¼ ½Ç¹«¸éÁ¢ - ¿Â¶óÀÎ ÀÎÀû¼º °Ë»ç - ½Å¿øÁ¶È¸ - ±Ù·Î°è¾à È®Á¤
*Á¦Ãâ ¼·ù :
1. ¿µ¹® ÀÚÀ¯À̷¼(ÀÚ±â¼Ò°³¼ ÅëÇÕÇÏ¿© ÇÑ °³ÀÇ ÆÄÀÏ·Î Áö¿øÇØÁÖ¼¼¿ä)
*¸ðÁý ±âÇÑ : ä¿ë ¸¶°¨ ½Ã ±îÁö
*´ã´çÀÚ ¹× ¿¬¶ôó : ÀλçºÎ ÃÖ¹ÎÁ¤(minjung.choi@merck.com)
*Áö¿ø À¯ÀÇ»çÇ× :
- °¡Á· »çÇ×, Áֹεî·Ï¹øÈ£´Â ±âÀÔÇÏÁö ¸»¾ÆÁֽʽÿÀ.
- ¼·ù ÇÕ°ÝÀÚ¿¡ ÇÑÇÏ¿© ¿¬¶ôµå¸³´Ï´Ù.
- pdf ȤÀº word ÆÄÀÏ·Î Áö¿ø ¹Ù¶ø´Ï´Ù.
Á¢¼ö±â°£
ä¿ë½Ã
Á¦Ãâ¼·ù
À̷¼
Á¢¼ö¹æ¹ý
À̸ÞÀÏ
À̷¼¾ç½Ä
Áö¿øÀÚ ÀÚÀ¯À̷¼ ¾ç½Ä
´ã´çÀÚ
Àλç´ã´çÀÚ
¿¬¶ôó
02-331-0000
À̸ÞÀÏ
minjung.choi@merck.com
ȸ»çÁÖ¼Ò
[04637] ¼¿ï Áß±¸ ÇÑ°´ë·Î 416 (³²´ë¹®·Î5°¡, ¼¿ï½ºÄù¾î)
ÃÖÁ¾¼öÁ¤ÀÏ : 2019³â 08¿ù 05ÀÏ
º» Á¤º¸´Â Çѱ¹MSD À¯ÇÑȸ»ç¿¡¼ Á¦°øÇÑ ÀÚ·áÀ̸ç, Æĸ¶¸ÞµðÀâ´Â(Àº) ±âÀçµÈ ³»¿ë¿¡ ´ëÇÑ ¿À·ù¿Í Áö¿¬, »ç¿ëÀÚ°¡ À̸¦ ½Å·ÚÇÏ¿© ÃëÇÑ Á¶Ä¡¿¡ ´ëÇÏ¿© Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. º» Á¤º¸´Â Æĸ¶¸ÞµðÀâÀÇ µ¿ÀÇ ¾øÀÌ Àç¹èÆ÷ÇÒ ¼ö ¾ø½À´Ï´Ù.
¼±ÅÃÇϽŠÀ̷¼¿Í ÀÔ·ÂÇϽŠ³»¿ëÀÌ ÇØ´ç¾÷üÀÇ ´ã´çÀÚ¿¡°Ô À̸ÞÀÏ·Î Àü¼ÛµË´Ï´Ù.
Áö¿øÀ̷¼
À̷¼¸¦ ¼±ÅÃÇØÁÖ¼¼¿ä
´ã´çÀÚ¸í
Àλç´ã´çÀÚ (minjung.choi@merck.com)
º¸³»´Â»ç¶÷
³»¿ë
°³ÀÎÁ¤º¸Ã³¸®¹æħ
|
ȸ¿ø¾à°ü
|
°í°´Áö¿ø¼¾ÅÍ
|
Á¦ÈÞ ¹× ±¤°í¹®ÀÇ
|
´ÙÀÌ·ºÆ®°áÁ¦
¼³¸³ÀÏ : 2015³â 12¿ù 02ÀÏ l °³ÀÎÁ¤º¸Ã¥ÀÓÀÚ : À±º´È£
Á÷¾÷Á¤º¸Á¦°ø»ç¾÷½Å°í¹øÈ£ J150002023003
»ç¾÷ÀÚµî·Ï¹øÈ£ : 285-18-01963
| Åë½ÅÆǸž÷½Å°í : Á¦ 2023-ÀÎõ-0450È£
Copyright ¨Ï
Æĸ¶¸ÞµðÀâ
Co. Ltd. All rights reserved.